AccuSite injectable gel of 5-fluorouracil and epinephrine data

A Phase II study demonstrated that 91 percent of evaluable treated skin cancers resolved completely

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE